Your browser doesn't support javascript.
loading
Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma.
Wentink, Madelon Q; Verheul, Henk M W; Pal, Sumanta K; George, Saby; Voortman, Johannes; Danchaivijitr, Pongwut; Adelaiye, Remi; Poslinski, Diane; Groman, Adrienne; Hutson, Alan; Pili, Roberto.
Afiliação
  • Wentink MQ; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Verheul HMW; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA.
  • George S; Genitourinary Program, Roswell Park Cancer Institute, Buffalo, NY.
  • Voortman J; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Danchaivijitr P; Genitourinary Program, Roswell Park Cancer Institute, Buffalo, NY.
  • Adelaiye R; Genitourinary Program, Roswell Park Cancer Institute, Buffalo, NY.
  • Poslinski D; Department of Clinical Research Services, Roswell Park Cancer Institute, Buffalo, NY.
  • Groman A; Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY.
  • Hutson A; Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY.
  • Pili R; Genitourinary Program, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN. Electronic address: rpili@iu.edu.
Clin Genitourin Cancer ; 2017 Jul 14.
Article em En | MEDLINE | ID: mdl-28781191
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article